ClinicalTrials.govpublic full text
A Study of JNJ-78278343, a T-Cell-Redirecting Agent Targeting Human Kallikrein 2 (KLK2), for Advanced Prostate Cancer
prostatic neoplasms, metastatic castration-resistant prostate cancer (mcrpc), advanced prostate cancer, interventional, phase1
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗Related documents
Record · ID 873740
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.